Graham G A Inglis

Title: The Innovative Contributions of Graham G A Inglis

Introduction

Graham G A Inglis is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-viral agents. With a total of two patents to his name, Inglis has demonstrated a commitment to advancing medical science through innovative solutions.

Latest Patents

Inglis's latest patents focus on dimeric compounds and their use as anti-viral agents. The invention relates to compounds of general formula (I), where R is an amino or guanidino group, Ris acetyl or trifluoroacetyl, and n is an integer from 10 to 18 or a pharmaceutically acceptable derivative thereof. These patents detail methods for the preparation of these compounds, pharmaceutical formulations containing them, and their use in the prevention or treatment of viral infections.

Career Highlights

Graham G A Inglis is currently associated with Biota Scientific Management Pty Ltd, where he continues to work on innovative pharmaceutical solutions. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.

Collaborations

Inglis has collaborated with notable colleagues such as Derek Anthony Demaine and Simon J F MacDonald. These partnerships have likely contributed to the success of his research and patent developments.

Conclusion

Graham G A Inglis exemplifies the spirit of innovation in the pharmaceutical industry through his work on anti-viral agents. His contributions are paving the way for advancements in the treatment of viral infections.